UNSPSC 51183622: Insulin aspart/Insulin aspart protamine

Insulin aspart protamine and insulin aspart is a combination of a fast-acting insulin and an intermediate-acting type of human insulin.

UNSPSC 51183622 Insulin aspart/Insulin aspart protamine is a Commodity code that does not appear in recent state and local procurement activity tracked in the source. The most-recent-state-local-contract-opportunities block contains no active solicitations or awarded contracts for insulin aspart or insulin aspart protamine products. The block includes only a single opportunity nominally tagged with a pharmaceutical-related code—a Seminole County, Florida IFB for Naloxone and Safe Drug Deactivation Systems (a different therapeutic class entirely)—along with a large multistate cooperative purchasing RFP for generic multi-source pharmaceuticals and OTC products that does not itemize insulins or specify insulin aspart formulations by name. The Tucson Fire Department's BLS/ALS pharmaceuticals RFP includes an estimated 251 line items of medications and medical supplies for emergency services but does not explicitly name insulin products. Without recent solicitation activity under this code, no issuing-body pattern, geographic concentration, or representative opportunities can be established from the source material.

The absence of recent state and local procurement activity under this Commodity code suggests limited or no current demand signaling in the markets tracked, or a possible taxonomic mismatch between how purchasing offices are tagging insulin-related procurements and this specific UNSPSC designation. Business development professionals should verify coding practices within target jurisdictions and consider whether insulin aspart/protamine is being procured under broader pharmaceutical or healthcare supply codes, or exclusively through standing cooperative purchasing vehicles not captured in recent RFP activity.